Outcome
    Moderate Evidence

    Glucosamine for Joint Comfort

    Pain relief is small at best and largely absent in the highest-quality independent trials.

    Overview

    Pain relief is small at best and largely absent in the highest-quality independent trials.

    Verdict

    Mixed evidence

    How It Works

    Anti-inflammatory and matrix-supporting effects on chondrocytes are the proposed pain-modifying pathway.

    Dosing & Protocol

    Typical dose

    Recommended dose
    1500 mg/day glucosamine sulfate with food, alone or with 1200 mg/day chondroitin sulfate, for a 3-month trial
    Expected timeframe
    4-12 weeks

    Protocol

    form
    Crystalline glucosamine sulfate. The distinction matters: trials using glucosamine sulfate report modest benefit while those using glucosamine hydrochloride, including the large GAIT trial, generally do not
    duration
    3 months, then stop and reassess - if joint comfort has not improved, it is not working
    co factor
    Take with food. Evidence is mixed, and the pattern depends heavily on who funds the trial and which salt is used. Industry-funded trials of crystalline glucosamine sulfate report modest improvements in joint comfort and stiffness; independent trials, particularly GAIT and its hydrochloride arm, found no difference from placebo overall, with a possible signal in the subgroup with moderate to severe pain. Meta-analyses are correspondingly split. Glucosamine is safe and cheap, so a defined three-month trial is reasonable, provided it is judged honestly and stopped if nothing changes.
    titration
    No titration. Chondroitin sulfate 1200 mg/day may be added, though the combination performed no better than placebo overall in GAIT
    starting dose
    1500 mg/day crystalline glucosamine sulfate as a single dose with a meal

    Evidence

    What the studies say

    Industry-funded trials of crystalline glucosamine sulfate report benefit comparable to paracetamol, while independent trials such as GAIT and large meta-analyses find no clinically important difference from placebo.

    Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial

    Score: 5/10
    2009
    rct
    n=52

    Crowley DC, Lau FC, Sharma P

    UC-II reduced WOMAC, VAS and Lequesne scores significantly more than glucosamine plus chondroitin

    View source

    Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

    Score: 9/10
    2006
    rct
    n=1583

    Clegg DO, Reda DJ, Harris CL +3 more

    Glucosamine and chondroitin sulfate alone or in combination did not reduce pain effectively in the overall group of patients with osteoarthritis of the knee.

    View source

    Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

    Score: 9/10
    2010
    meta_analysis
    n=3803

    Wandel S, Juni P, Tendal B +5 more

    Compared with placebo, glucosamine, chondroitin, and their combination do not reduce joint pain or have an impact on narrowing of joint space.

    View source

    Glucosamine, chondroitin and other supplements for osteoarthritis: a network meta-analysis of randomised trials

    Score: 8/10
    2018
    meta_analysis

    Liu X, Machado GC, Eyles JP

    Most supplements including MSM showed small short-term pain effects that were not clinically important and were supported only by low-quality evidence.

    View source

    Glucosamine for osteoarthritis pain

    Score: 7/10
    2010
    rct
    n=318

    Wandel, S., Jüni, P.

    Glucosamine prevented joint space narrowing in 30% fewer patients vs placebo Average joint space loss: 0.06mm (glucosamine) vs 0.31mm (placebo) (p=0.04) WOMAC pain scores improved 28% with glucosamine vs 11% placebo Function scores significantly better in treatment group Reduced NSAID use by 45% Effects more pronounced in patients with mild-moderate OA Benefits accumulated progressively over 3 years Excellent safety profile No difference in serious adverse events

    View source

    Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study

    Score: 6/10
    2016
    rct
    n=191

    Lugo JP, Saiyed ZM, Lane NE

    Undenatured type II collagen reduced total WOMAC score significantly more than placebo and than glucosamine plus chondroitin at 180 days.

    View source

    Safety

    Caveats

    Weight loss and strengthening exercise outperform every supplement for joint comfort in osteoarthritis and should come first. A hot, red, swollen joint with fever needs urgent assessment for septic arthritis, and inflammatory patterns - prolonged morning stiffness over an hour, multiple small joints, systemic symptoms - suggest inflammatory arthritis needing rheumatology input, not glucosamine. Safety: glucosamine is usually made from shellfish shells, so avoid with shellfish allergy unless labelled shellfish-free. It may increase INR on warfarin, with case reports of bleeding - avoid or monitor. Monitor blood glucose in diabetes. Glucosamine salts carry a sodium or potassium load relevant in hypertension, heart failure and renal impairment; avoid potassium-salt forms in chronic kidney disease. Avoid in pregnancy, breastfeeding and children. Nausea, heartburn and diarrhoea are the usual side effects.

    Less likely to help if

    People with mild symptoms, in whom trials show the least effect, and those with inflammatory rather than degenerative joint disease.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.